schliessen

Filtern

 

Bibliotheken

Management of Antimicrobials in Infectious Diseases : Impact of Antibiotic Resistance / edited by Arch G. Mainous III, Claire Pomeroy

Recent evidence suggests an increasing rate of antimicrobial resistant pathogens throughout the world. Pathogens like Staphylococcus aureus are showing substantial prevalence of resistance to antibiotics. Thus, we think that given these developments, clinicians would welcome an updated version of th... Full description

PPN (Catalogue-ID): 664544304
Personen: Mainous III, Arch G.
Pomeroy, Claire
Format: eBook eBook
Enthält: Preface; Acknowledgements; Contents; Contributors; Antibiotic Resistance and Implications for the Appropriate Use of Antimicrobial Agents; 1 Introduction; 2 Background and Epidemiology of Resistant Pathogens; 2.1 Level of Antimicrobial Resistance; 2.2 Implications for Morbidity and Mortality; 3 Cell Physiology and Genetics of Antimicrobial Drug Resistance; 3.1 Cellular Physiologic Mechanisms; 3.2 Genetic Basis for Resistance; 3.3 Chromosomal Mutations; 3.4 Inducible Mechanisms; 4 Measuring Antimicrobial Resistance; 4.1 Laboratory Testing; 4.2 Surveillance
Language: English
Published: Totowa, NJ, Humana Press, 2010
Edition: 2. ed.
Series: Infectious Disease
Subject Area (NLM): WC 195
Basisklassifikation: 44.75
Subjects:

Infection / drug therapy

Anti-Infective Agents / therapeutic use

Communicable Diseases / drug therapy

Notes: Description based upon print version of record
Physical Description: Online-Ressource, v.: digital.
ISBN: 978-1-60327-239-1
Sekundärausgabe Online-Ausg., 2010, Springer eBook Collection. Medicine

Similar Items

Vorhandene Hefte/Bände

more (+)

Informationen zur Verfügbarkeit werden geladen

Staff View
LEADER 09376cam a22010692 4500
001 664544304
003 DE-627
005 20190310012253.0
007 cr uuu---uuuuu
008 110721s2010 xx |||||o 00| ||eng c
020 |a 9781603272391  |9 978-1-60327-239-1 
024 7 |a 10.1007/978-1-60327-239-1  |2 doi 
035 |a (DE-627)664544304 
035 |a (DE-599)GBV664544304 
035 |a (OCoLC)838136977 
035 |a (DE-He213)9781603272391 
035 |a (EBC)EBC993459 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
050 0 |a QR1-502 
060 0 |a WC 195 
082 0 |a 616.9041 
084 |a 44.75  |2 bkl 
245 1 0 |a Management of Antimicrobials in Infectious Diseases  |b Impact of Antibiotic Resistance  |c edited by Arch G. Mainous III, Claire Pomeroy 
250 |a 2. ed. 
264 1 |a Totowa, NJ  |b Humana Press  |c 2010 
300 |a Online-Ressource  |b v.: digital 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
490 0 |a Infectious Disease 
500 |a Description based upon print version of record 
501 |a Preface; Acknowledgements; Contents; Contributors; Antibiotic Resistance and Implications for the Appropriate Use of Antimicrobial Agents; 1 Introduction; 2 Background and Epidemiology of Resistant Pathogens; 2.1 Level of Antimicrobial Resistance; 2.2 Implications for Morbidity and Mortality; 3 Cell Physiology and Genetics of Antimicrobial Drug Resistance; 3.1 Cellular Physiologic Mechanisms; 3.2 Genetic Basis for Resistance; 3.3 Chromosomal Mutations; 3.4 Inducible Mechanisms; 4 Measuring Antimicrobial Resistance; 4.1 Laboratory Testing; 4.2 Surveillance 
501 |a 5 Factors Promoting Antimicrobial Resistance and Measures to Control Its Spread5.1 Community-Acquired Pathogens; 5.2 Hospital-Acquired Pathogens; 6 Key Points; References; Part I Significant Pathogens; Antimicrobial Resistance Among Epidemiologically Important Gram-Positive Bacteria; 1 Introduction; 2 Streptococcus pneumoniae; 3 Staphylococcus aureus; 3.1 Healthcare-Associated MRSA; 4 Community-Associated MRSA; 5 Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Resistant Staphylococcus aureus; 6 Enterococcus Species; 7 Conclusion; References 
501 |a Gram-Negative Bacteria1 Introduction; 2 Beta-Lactam Antibiotics: Activity and Resistance; 3 Fluoroquinolones: Activity and Resistance; 4 Aminoglycosides: Activity and Resistance; 5 Gram-Negative Organisms; 5.1 Escherichia coli; 5.2 Klebsiella pneumoniae; 5.3 Pseudomonas aeruginosa; 5.4 Acinetobacter baumannii; 6 Role of the Primary Care Provider in Managing Gram-Negative Infections; 7 Lack of New Agents in the Development Pipeline; 8 Key Points; References; Tuberculosis; 1 Epidemiology; 2 Drug Resistance; 3 Treatment of Drug-Susceptible TB Disease; 3.1 General 
501 |a 3.2 Directly Observed Therapy (DOT) and Combination Antimicrobial Preparations3.3 Considerations for Patients Co-infected with HIV; 4 Treatment of Drug-Resistant TB Disease; 5 Preventive Regimens for TB Disease (Treatment of Latent TB Infection); 6 Key Points; References; Community-Acquired Viral Infections; 1 Influenza Virus; 1.1 Virology; 1.2 Epidemiology; 1.3 Clinical Syndromes; 1.4 Diagnosis; 1.5 Prevention; 1.6 Treatment; 1.7 Antiviral Resistance; 2 Herpes Simplex Viruses; 2.1 Virology; 2.2 Clinical Syndromes; 2.2.1 Mucocutaneous Infection; 2.2.2 Neonatal Disease 
501 |a 2.2.3 Keratoconjunctivitis2.2.4 HIV and HSV; 2.2.5 CNS Infections; 2.2.6 HSV in Pregnancy; 2.3 Treatment; 2.4 Pregnancy; 2.5 Resistance in Immunocompromised Patients; 3 Varicella Zoster Virus; 3.1 Epidemiology; 3.2 Clinical Syndromes; 3.2.1 Varicella; 3.2.2 Herpes Zoster; 3.3 Diagnosis; 3.4 Antiviral Therapy; 3.5 Prevention; 3.5.1 Post-exposure Prophylaxis; 3.5.2 Vaccination; 4 Respiratory Syncytial Virus; 4.1 Virology and Epidemiology; 4.2 Disease Pathogenesis; 4.3 Neonatal Infection; 4.4 Infection in Infants; 4.5 Childhood Infection; 4.6 Infection in Adults and the Elderly; 4.7 Diagnosis 
501 |a 4.8 Treatment 
520 |a Recent evidence suggests an increasing rate of antimicrobial resistant pathogens throughout the world. Pathogens like Staphylococcus aureus are showing substantial prevalence of resistance to antibiotics. Thus, we think that given these developments, clinicians would welcome an updated version of this book. A resource indicating appropriate, evidence-based antimicrobial treatment of infectious diseases encountered in both the hospital and outpatient settings would be of significant value to practicing clinicians. The book would focus on the clinical importance of appropriate diagnosis and trea 
533 |a Online-Ausg.  |d 2010  |7 |2010||||||||||  |f Springer eBook Collection. Medicine 
653 2 |a Infection / drug therapy 
653 2 |a Anti-Infective Agents / therapeutic use 
653 2 |a Communicable Diseases / drug therapy 
700 1 |a Mainous III, Arch G. 
700 1 |a Pomeroy, Claire 
776 1 |z 9781603272384  |9 978-1-60327-238-4 
776 0 8 |i Print version  |a Management of Antimicrobials in Infectious Diseases : Impact of Antibiotic Resistance 
856 4 0 |u http://dx.doi.org/10.1007/978-1-60327-239-1  |x Resolving-System  |z Lizenzpflichtig  |3 Volltext 
856 4 0 |u http://gbv.eblib.com/patron/FullRecord.aspx?p=993459  |x Verlag  |3 Volltext 
856 4 0 |u https://ebookcentral.proquest.com/lib/gbv/detail.action?docID=993459  |x Aggregator  |3 Volltext 
912 |a H-ZDB-2-SME  |b 2010 
912 |a H-ZDB-30-PQE 
912 |a GBV_ILN_22 
912 |a SYSFLAG_1 
912 |a GBV_KXP 
912 |a GBV_ILN_22_i06404 
912 |a GBV_ILN_74 
912 |a GBV_ILN_100 
912 |a GBV_ILN_101 
912 |a GBV_ILN_206 
912 |a GBV_ILN_252 
935 |h GBV  |i hybr 
936 b k |a 44.75  |j Infektionskrankheiten  |j parasitäre Krankheiten  |x Medizin  |0 (DE-627)106415948 
951 |a BO 
980 |2 22  |1 01  |b 125718010X  |h OLR-SEB  |k Campuslizenz Universität Hamburg. - Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.  |l h64 2011-08-25  |x 0018  |y zi06404  |z 26-07-11 
980 |2 74  |1 01  |b 1286506573  |f E-Bibl  |d EK 0043  |h OLR-ESP  |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden.  |x 0354  |y ze  |z 25-04-12 
980 |2 100  |1 01  |b 125722963X  |d eBook Springer  |h OLR-SEB  |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.  |x 3100  |y z  |z 26-07-11 
980 |2 101  |1 01  |b 1257245546  |d eBook Springer  |h OLR-SEB  |k Vervielfältigungen (z.B. Kopien, Downloads) sind nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte. Kein systematisches Downloaden durch Robots.  |x 3101  |y z  |z 26-07-11 
980 |2 206  |1 01  |b 1553955447  |d Online-Ressource  |e g  |h OLR-EBL  |k Please send a request, if the ebook is not available!  |l E-Books (Schweitzer)  |x 3350  |y zh  |z 17-07-15 
980 |2 252  |1 01  |b 1628853689  |f Thünen-Institut  |d Online-Ressource  |e g  |h OLR-EBL  |k Ebook noch nicht erworben! Nach dem Kauf: Vervielfältigungen (z. B. Kopien, Downloads) sind nur von einzelnen Kapiteln oder Seiten und nur zum eigenen wissenschaftlichen Gebrauch erlaubt. Keine Weitergabe an Dritte.  |l E-Books (Schweitzer)  |x 4252  |y zi070e  |z 01-08-16 
981 |2 22  |1 01  |y Volltextzugang  |r http://dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 22  |1 01  |y Nur für Angehörige der Universität Hamburg: Volltextzugang von außerhalb des Campus  |r http://emedien.sub.uni-hamburg.de/han/SpringerEbooksUKE/dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 74  |1 01  |y Volltext, Campuszugriff  |r http://dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 74  |1 01  |y Volltext, Externer Zugriff  |r http://HAN.mh-hannover.de/han/springer-ebook/dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 100  |1 01  |r http://dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 100  |1 01  |y für Uniangehörige: Zugang weltweit  |r http://han.med.uni-magdeburg.de/han/SPR-eBook-Medicine-einzeln/dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 101  |1 01  |r http://dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 101  |1 01  |y für Uniangehörige: Zugang weltweit  |r http://han.med.uni-magdeburg.de/han/SPR-eBook-Medicine-einzeln/dx.doi.org/10.1007/978-1-60327-239-1 
981 |2 206  |1 01  |y Fulltext  |r https://thh-friedensau.idm.oclc.org/login?url=https://ebookcentral.proquest.com/lib/thhfriedensau/detail.action?docID=993459 
981 |2 252  |1 01  |y Zeitlich begrenzter Lesezugriff nur für Angehörige des Thünen-Instituts  |r http://ebookcentral.proquest.com/lib/thinst/detail.action?docID=993459 
982 |2 74  |1 00  |8 00  |a Infection-drug therapy 
982 |2 74  |1 00  |8 01  |a Anti Infective Agents-therapeutic use 
982 |2 74  |1 00  |8 02  |a Communicable Diseases-drug therapy 
983 |2 74  |1 00  |8 00  |a WC 195 
985 |2 22  |1 01  |a h64 ebook 
985 |2 74  |1 01  |a EK 0043 
985 |2 74  |1 01  |a EM 1841 
995 |2 22  |1 01  |a OLR-SEB 
995 |2 74  |1 01  |a OLR-ESP 
995 |2 100  |1 01  |a OLR-SEB 
995 |2 101  |1 01  |a OLR-SEB 
995 |2 206  |1 01  |a OLR-EBL 
995 |2 252  |1 01  |a OLR-EBL